Buy Aurobindo Pharma, target Rs 785: Shrikant Chouhan
Buy Aurobindo Pharma at a price target of Rs 785 and a stop loss at Rs 732 from entry point.
By ETMarkets.com |
Shrikant Chouhan of Kotak Securities Limited has a buy call on Aurobindo Pharma with a target price of Rs 785.
The current market price of Aurobindo Pharma is Rs 745.15.
Time period given by the analyst is intraday when Aurobindo Pharma price can reach defined target.
Shrikant Chouhan recommended to keep a stop loss at Rs 732.
Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 43,657.03 Crore) operating in Pharmaceuticals and health care sector.
Aurobindo Pharma key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9,532.19 Crore to Sales Value (97.45 per cent of Total Sales), Export Incentives which contributed Rs 233.20 Crore to Sales Value (2.38 per cent of Total Sales), Scrap which contributed Rs 8.65 Crore to Sales Value (0.08 per cent of Total Sales) and Sale of services which contributed Rs 7.17 Crore to Sales Value (0.07 per cent of Total Sales)for the year ending 31-Mar-2017.
The company’s top management includes Dr.M Sivakumaran, Dr.(Mrs.)Avnit Bimal Singh, Mr.K Nithyananda Reddy, Mr.K Ragunathan, Mr.M Madan Mohan Reddy, Mr.M Sitarama Murthy, Mr.N Govindarajan, Mr.P Sarath Chandra Reddy, Mr.P V Ramprasad Reddy, Mr.Rangaswamy Rathakrishnan Iyer.
Company has BSR & Associates LLP as its auditors.
As on 30-06-2017, the company has a total of 585,882,409 shares outstanding.
The current market price of Aurobindo Pharma is Rs 745.15.
Time period given by the analyst is intraday when Aurobindo Pharma price can reach defined target.
Shrikant Chouhan recommended to keep a stop loss at Rs 732.
Aurobindo Pharma, incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 43,657.03 Crore) operating in Pharmaceuticals and health care sector.
Aurobindo Pharma key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9,532.19 Crore to Sales Value (97.45 per cent of Total Sales), Export Incentives which contributed Rs 233.20 Crore to Sales Value (2.38 per cent of Total Sales), Scrap which contributed Rs 8.65 Crore to Sales Value (0.08 per cent of Total Sales) and Sale of services which contributed Rs 7.17 Crore to Sales Value (0.07 per cent of Total Sales)for the year ending 31-Mar-2017.
ADVERTISEMENT
The company’s top management includes Dr.M Sivakumaran, Dr.(Mrs.)Avnit Bimal Singh, Mr.K Nithyananda Reddy, Mr.K Ragunathan, Mr.M Madan Mohan Reddy, Mr.M Sitarama Murthy, Mr.N Govindarajan, Mr.P Sarath Chandra Reddy, Mr.P V Ramprasad Reddy, Mr.Rangaswamy Rathakrishnan Iyer.
Company has BSR & Associates LLP as its auditors.
As on 30-06-2017, the company has a total of 585,882,409 shares outstanding.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
